Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Amgen beats Sanofi to PCSK9 inhibitor market

Amgen beats Sanofi to PCSK9 inhibitor market first to launch in the US after buying a priority review voucher from BioMarin last year.

BioMarin drug boosts growth in children with dwarfism

BioMarin drug boosts growth in children with dwarfism Vosoritide showed results in 50% of trial participants. A drug in development at BioMarin has increased growth rates in children with dwarfism in 50%, raising hopes for the first effective therapy ... BioMarin is a rare disease specialist and already

Praluent and Repatha backed for approval in US

Praluent and Repatha backed for approval in US The FDA's review date for Praluent is July 24 - accelerated thanks to Sanofi's purchase of a priority review voucher from BioMarin last year - while the agency is due to

BioMarin files muscular dystrophy drug in EU

BioMarin files muscular dystrophy drug in EU Drisapersen could be the first ‘exon-skipping’ therapy. BioMarin has filed its Duchenne muscular dystrophy (DMD) drug drisapersen in Europe, raising expectations of a second approved therapy for the disorder. ... BioMarin acquired rights to

Shire rumoured to be pursuing Actelion

Shire rumoured to be pursuing Actelion Other transactions including rare disease companies of late include Horizon Pharma's $1.1bn deal to buy urea cycle disorder specialist Hyperion Therapeutics and BioMarin $840m purchase of Prosensa in order

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....

Infographics